Personalized laboratory medicine: Results of an european survey conducted by the EFLM/ESPT WG-PLM

M. Pazzagli, F. Malentacchi, I. Mancini, I. Brandslund, P. Vermeersch, M. Schwab, J. Marc, E. Theodorsson, R. Van Schaik, C. Di Resta

Research output: Contribution to journalConference abstract in journalResearchpeer-review


Developments in "omics" are creating a paradigm shift in Laboratory Medicine leading to Personalised Medicine. This allows the increasing in diagnostics and therapeutics focused on individuals rather than populations. In order to investigate whether Laboratory Medicine is able to implement new diagnostic tools and expertise and commands proper state-of-the-art knowledge about Personalized Medicine and Laboratory Medicine in Europe, the joint Working Group "Personalized Laboratory Medicine" of the EFLM and ESPT societies compiled and conducted the Questionnaire "Is Laboratory Medicine ready for the era of Personalized Medicine?". 48 laboratories from 18 European countries participated at this survey. The answers of the participating Laboratory Medicine professionals indicate that they are aware that Personalized Medicine can represent a new and promising health model. Whereas they are aware that Laboratory Medicine should play a key role to support the implementation of Personalized Medicine in the clinical settings, the participants of this survey think that the current organization of the Laboratory Medicine needs additional/relevant implementations such as: 1. New technological Facilities in "omics"; 2. Additional training for the current personnel focused on the new methodologies; 3. Incorporation in the Laboratory of new competencies in data interpretation and counselling; 4. Improving cooperation and collaboration between professionals of different disciplines to integrate information suitable for a Personalized Medicine approach. This survey suggest a strategic plan that should be considered by both health care providers and scientific societies of Laboratory Medicine. The implementation of Personalized Medicine should be first tested in a limited number of centers (Academic / Hospitals) possessing a wide range of competencies and facilities in "-omics" and in bioinformatics. These centers should then be supported to gain the missing technological facilities and appropriately trained for this aim.
Original languageEnglish
JournalClinical Chemistry and Laboratory Medicine
Issue numberS1
Pages (from-to)S24
Number of pages1
Publication statusPublished - 2015
Event 21st IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicine - Paris, France
Duration: 21. Jun 201525. Jun 2015


Conference 21st IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicine

Cite this